Peripheral monocytes from patients with common variable immunodeficiency (CVID) had on average a 2 fold greater tendency to form giant cells in medium without additional cytokines. Giant cell formation was faster and 3 to 5 fold higher in most CVID cells compared to normal. Addition of IL4, GMCSF, IFNγ, TNFa and both T cell and monocyte conditioned media promoted monocyte fusion of some CVID individuals over 5 fold the normal average level, with combinations of cytokines and monokines acting synergistically. The reduction of normal giant cell formation by anti-IFNγ antibody and a greater tendency of CVID cells to fuse in immunoglobulin conditioned media suggests that standard IVIg treatment contributes to granuloma formation. CVID and normal giant cells expressed similar levels of phenotypic molecules and had similar phagocytic activity. Monocytes from many CVID patients have an elevated tendency to fuse which may explain the high incidence of granulomatous complications in CVID.
Introduction
Multinucleated cells are observed regularly in the immune response to malignancy (Cohen and Kurzrock, 2007) , and some microbial and parasitic diseases (El-Zammar and Katzenstein, 2007) . First reported in patients with tuberculosis over a century ago, multinucleated giant cells are formed by macrophage fusion (Kreipe et al., 1988) and represent an end-point in myeloid cell lineage development. Giant cells are a regular feature of the immune response to diseases characterised by pathogen survival in phagocytes, such as leprosy, syphilis and aspergillosis (Segal et al., 1998) ; they are also a component of chronic inflammatory reactions to parasites, including schistosomiasis, Leishmania and Filaria (Bentley et al., 1985) . Non-caseating epithelioid cell granulomas occur in about 10% of patients with Hodgkin's lymphoma, and less frequently in other malignant conditions (Brincker,1986) , particularly lung, prostate and some skin tumours (Kornacker et al., 2002; Kurata et al., 2005) .
Granulomatous reactions centred round multinucleate giant cells are a pathological feature of a variety of inflammatory diseases, including sarcoidosis, Crohn's disease and rheumatoid arthritis (Barnard and Newman, 2001) . Epithelioid or giant cells, which form the centre of granulomatous reactions, are generated in these diseases from macrophages by the action of inflammatory cytokines (Kasahara et al., 1989) .
Granulomatous reactions are a recognised feature of common variable immunodeficiency (CVID) with about 20% of patients developing unexplained chronic inflammation, often with granuloma formation, involving many different organs, most commonly the spleen, lymph nodes, liver or lungs (Ardeniz and Cunningham-Rundles, 2009; Bates et al., 2004) . Although recurrent bacterial infections due to failure of antibody production is the predominant clinical problem in CVID, the circulating T cells and monocytes in many patients show features of persistent activation (Holm et al., 
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4 2006), with evidence that herpes viruses provide a major inflammatory stimulus in some patients (Marashi et al., 2012) . CVID monocytes generally generate defective dendritic cells with deficient major histocompatibility complex (MHC) class II DR expression (Scott-Taylor et al., 2004) which induce poor T cell proliferation and abnormal cytokine production (Bavry et al., 2005; Cunningham-Rundles and Radigan, 2005) . Abnormal monocyte responses may contribute to a polarised Th1 immune phenotype in CVID, with exacerbated T cell IL-12 production (Cambronero et al., 2000) and increased IL-12 receptor expression (McQuaid et al., 2000) , promoting a high incidence of granulomatous infiltration of lymphoid and other tissues (Webster, 2001) . In this study,
we have investigated the formation of giant cells from CVID monocytes, which could explain the abnormally high rate of granuloma formation in CVID and elucidate the process of inflammatory polarisation in some CVID individuals. separated on Lymphoprep (Axis-Shield ProC As, density 1.077 g/ml) after centrifugation.
Plasma supernatants were collected, clarified by centrifugation at 500 x g and used to culture autologous cells. PBMCs were washed twice in medium to reduce platelets and then seeded into 6 well plates (Nunc 152795, Sigma-Aldrich, Poole, Dorset). Routine monitoring of immunologic parameters was performed by the Clinical Immunology
Service of the Royal Free Hospital using isotype controls in parallel with each batch of samples analyzed. Peptide stimulation of T cells was performed on fresh PBMCs stimulated with 10 mg/mL CMV or EBV peptides or without peptide in the presence of anti-CD28 (10 mg/mL) antibody and brefeldin A (10 mg/mL, Sigma-Aldrich) as previously described (Marashi et al., 2012) . PBMCs were stained with the appropriate HLA pentamer (10 mg/mL) for 15 minutes at room temperature, washed with PBS containing 0.1% sodium azide, stained for 15 minutes at room temperature with CD8 FITC and PD-1 APC antibodies (Pharmingen 551347 and 558694), fixed and permeabilized (Fix &
6 Perm Kit, GAS-002, Caltag Medsystems) and stained with a PE-conjugated antibody to granzyme B (Pharmingen, 561142). T cell clonal analysis was performed immediately on a FACSCalibur flow cytometer using a minimum of 50,000 events. Individuals with a >1% total T cell reactivity with CMV tetrameric reagents were designated CMV positive (Table 1) .
Adherent monocytes were selected in 2 successive 2 hr. incubations in 6 well plates, from which non adherent cells were carefully washed off and adherent cells eluted by incubation with 5mM EDTA for use in fusion assays. CD14+ monocytes were purified to <98% using an MS column (130-042-201, Miltenyi Biotech, Bisley, Surrey) containing magnetic sheep anti-mouse IgG coated beads (Dynal Biotech, 120-000-305) incubated with 1 ug/ml CD14 antibody (BD PharMingen, San Jose, CA, 550376) for 30 minutes. B lymphocytes (>95% purity) were selected with CD19+ magnetic beads (Miltenyi Biotech, ) from the non-adherent cell fraction before T lymphocytes (> 98% CD3+ purity by flow cytometry) were separated by 2 rounds of negative selection using a mixed antibody (Miltenyi Biotech, . CD14+ monocytes were cultured in X vivo 15 medium with 10% autologous plasma or 10% heat treated (56°C for 30 min) AB serum (Sera-Lab S-11-J, Haywards Heath, West Sussex) at a density of 5 x10 5 per ml at 37°C in a humidified atmosphere containing 5% CO 2 with a variety of cytokines and mitogens for 7 days. TNF, IFN or IL1 (5 to 50 ng/ml, Peprotech EC, London) were added to some cultures; some culture wells were coated with 10% BSA or type1collagen (Sigma-Aldrich, C3867) in coating buffer (50mM Na 2 CO 3 , pH = 9.5) overnight at 4°C. Cell viability was monitored by trypan blue exclusion and media including cytokine reagents changed every third day of culture. LPS contamination of media contamination of media (Limulus Amoeba Lysate kit, Quadratech Ltd, Epsom, Surrey) was below 15 ng/ml.
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T cell conditioned media were generated from normal and CVID T lymphocytes incubated overnight in 6 well plates at a density of 1 x10 7 cells per ml with 1 ug/ml PHA (nPHA and cPHA, respectively) or in wells coated with 20 ug/ml anti-CD3 antibody (nCD3 and cCD3). Antibody coated plates were washed three times with cation-free phosphate buffered saline before use. Normal and CVID monocyte conditioned media was collected from 1x 10 7 pooled purified CD14+ normal and patient cells incubated overnight in 6 well plates coated with 10 mg/mL human gamma globulin (Sandoglobulin, CSL Behring, Haywards Heath) (nIVIG and cIVIG, respectively) or 200 nmol/mL phorbol myristate acetate (Sigma Aldrich) (nPMA and cPMA, respectively). Cell supernatant was clarified by centrifugation for 10 minutes at 500 xg, passed through 0.2 um nonpyrogenic syringe filters and stored at -70°C in 1 ml aliquots. The cell-free conditioned medium was added to monocyte or PBMC cultures at a final concentration of 50% in at least 3 experiments with different conditioned media.
Immature monocyte derived dendritic cells (MdDC) were generated from adherent monocytes after 6 days of culture in X vivo 15 supplemented with 20% autologous plasma, 100 ng/ml GM CSF and 50 ng/ml IL4 (PeproTech EC, London, AF-300-03 and AF-200-04). MdDC were washed and applied to poly-L-lysine (P4832, Sigma-Aldrich, Poole Dorset) treated glass coverslips in 200 ul drops of fresh X vivo 15 at 10 6 cell/ml in 6 well plates. After 1 hour incubation in a humidified chamber, coverslips were gently submerged in 3 ml of X vivo 15 medium supplemented with 100 ng/ml GM CSF and 50 ng/ml IL4.
The influence of maturation and differentiation agents on giant cell formation was investigated with or without autologous plasma with the addition of cytokines; GM CSF or
G CSF, (Peprotech EC, AF-300-23, 100 ng/ml), IL4 and TNF (Peprotech EC, AF-300-01a, 20 ng/ml), IFN (5-20 ng/ml), IL1 (10 ng/ml), IL10 (5 and 10 ng/ml) (Peprotech EC, AF-300-02, AF-200-01a and AF-200-10) or mitogens PMA and PHA (2.5-10 ng/ml, P1585 and L2769, Sigma-Aldrich) added at various times to different cultures. CD3
antibody (OKT3 cell supernatant) was used to coat some wells at 5 ug/ml in phosphate buffer overnight prior to the addition of cells. Anti-IFN antibody (Remicade, 100 mg/ml) was added to cytokine cultured cells at a concentration of 1 ug/ml for 5 days prior to harvest. Wells were flooded and media exchanged gently by pipette to minimise disturbance throughout. At various time points as described, cells were fixed in ice cold 2% paraformaldehyde PBS for 30 minutes at 4°C and stained with Wright Giemsa stain.
To investigate the effect of differentiation on fusion, cell were preincubated for 15 minutes in X vivo 15 medium without FBS in 10 uM phalloidin FITC, phalloidin oleate and 
Statistical analysis
Statistical analyses were performed using SPSS for Windows. Levels of cytokines and numbers of cells expressing surface molecules were tested using an independent sample two-tailed t-test (assuming normal distribution of data), and by the MannWhitney test for nonparametric data. Spearman's Rho test was used to assess correlation. P-values < 0·05 were considered significant.
Results
Morphology And Formation Of Giant Cells
Culture 
Kinetics Of Giant Cell Formation In CVID
When monocytes from CVID patients were cultured with GM CSF and IL4 multinucleated cells were observed after day 2 of culture ( Figure 1C ), increased till day 5
( Figure 1D ) and were generally complete by day 7 of culture. The fusion rate of adherent monocytes was examined in cultured cells from 9 CVID and normal individuals over 9 days of incubation in GM CSF and IL4. Figure 2A shows there was a 2.2 fold average higher number of giant cells at day 9 with CVID monocytes when compare to cells from healthy controls, although there was wide variation between cells from different patients. +/-1.9, mean FI+/-SD, respectively, n = 6), increases of 2.6 and 3.2 fold, respectively, over the normal basal fusion index without reagents. CVID cell fusion indices with GM
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CSF and IL4, (9.3 +/-5.9 and 13.7 +/-3.7 FI+/-SD, respectively, n = 6) were 1.9 and 2.8 fold higher than CVID basal rates. Induction of multinucleate cells by a combination of GM CSF and IL4 was additive, together generating 3.9 and 4.8 fold increases in the fusion index of CVID and normal monocytes (n = 6), respectively, over the basal rates without cytokines. CVID fusion indices with GM CSF and or IL4 were higher than normal +/-3.2 mean FI +/-SD, n = 5 CVID individuals, nPMA and cPMA, respectively). CD3 generated conditioned media of normal cells (nCD3, Figure 3B ) also had potent effects on the fusion indices of CVID cells and less effect with normal cells (20.6 +/-4.8 and 14.6 +/-5.7 mean FI +/-SD, n = 5 normal and CVID individuals, respectively). CD3 generated conditioned media with CVID cells (cCD3) was also relatively more effective with CVID CD14+ cells but was less potent than other conditioned media (12.9 +/-4.8 and 10.6 +/-2.4 mean FI +/-SD, n = 5 CVID and normal individuals, respectively).
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Conditioned medium generated with PHA from normal cells was highly potent and again relatively more effective with CVID CD14+ cells (nPHA FI +/-SD = 23.4 +/-4.6 and 17.8 +/-4.0, n = 6 normal and CVID individuals, respectively) while conditioned medium generated with PHA from CVID cells was much less effective with either normal or CVID CD14+ cells (cPHA FI +/-SD = 11.7 +/-2.1 and 11.2 +/-3.1, n = 5 normal and CVID individuals respectively. The use of monocyte media conditioned with gamma globulin also demonstrated a difference between normal and CVID cells. Monocyte conditioned media produced by normal cells (nIVIg) generated only marginally more giant cells than basal levels but media from CVID monocytes stimulated with IVIg generated 3.9 and 4.9
fold increases in fusion index of normal and CVID cells, respectively, (10.3 +/-2.9 and 14.8 +/-5.3 mean FI +/-SD, n = 6 normal and CVID individuals, respectively) over plasma alone.
Giant Cell Function
Centrifugation of monocytes cultured with GM CSF and IL4 onto coverslips in tissue culture plates promoted formation of very large giant cells. Optimal plasticity in fusion in both normal and CVID cells occurred after 2 to 3 days and before day 5 of culture. The arrangement of nuclei in these large giant cells (Figure 4 ) was predominantly central but seldom symmetrically or circularly organized. Peripheral nuclei continued to fuse with the main body after the initial fusion event, but newly incorporated nuclei were not repositioned. 1 um confocal optical slices in phalloidin FITC treated cells ( Figure 4B) show the nuclei to be scattered in the cytoplasm in an irregular arrangement at varying heights above the substrate. Central nuclei were embedded in an intricate meshwork of F-actin microfibrils, while peripheral nuclei were associated with larger actin microfibers.
Preincubation of monocytes in phalloidin oleate reduced syncytial formation and resulted Examination of giant cells in transverse electron microscopy ( Figure 5A ) showed many small dense mitochondria with well-developed cristae amid rough-surfaced endoplasmic reticulum (RER) associated with the nuclei. The cytoplasm was crowded with dense lysosomal bodies, microfibrils, microtubules and lipid droplets mingled with the mitochondria. Granular vesicles were frequently associated with membrane whorls and toriodal structures ( Figure 5B ), indicating intense membrane reorganization. Golgi apparati, centrosomes and free ribosomes were evident but no structural features particular to either normal or CVID giant cells were discerned.
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Giant cells generated in culture were highly phagocytic, engulfing uncoated and opsonized yeast and bacteria. Figure 5C shows a single CVID giant cell with a large number of ingested yeast particles at various stages of digestion. When re-exposed to yeast particles a day or more later, giant cells would incorporate more particles. Both normal and CVID giant cells incorporated sufficient quantities of carboxylated beads to distort the cellular shape and contents ( Figure 5D ). Trypsinized bead-treated cells examined by flow cytometry showed an inverse relationship between the numbers of nuclei and the numbers of beads incorporated (data not shown) but it was not possible to demonstrate a difference in phagocytic capacity of normal and CVID monocytic syncytia with fluorescent bacteria, opsonized or uncoated yeast or carboxylated beads.
Discussion
Giant cells are formed from monocytes in response to a variety of stimuli and in certain inflammatory diseases (Heresbach et al., 2005; Mizumo et al., 2000) . phagocytic giant cells suggests that more mature giant cells were proportionally less phagocytic than monocytes. Phalloidin staining showed centralised nuclei embedded in a diffuse network of actin microfilaments whereas peripheral nuclei were often linked to larger bundles of fibres. Phalloidin oleate, a cell permeable inhibitor of stable actin formation, and cytochalasin D which affects actin filament elongation (Bear et al., 2002) prevented nuclear aggregation and reduced the fusion index, suggesting that actin microfilament elongation enabled nuclear reorganisation in giant cells and has a role in cell fusion.
CVID giant cells had higher number of nuclei and were formed earlier in culture than normal giant cells. Accumulation of multicellular nuclei in later stages of culture occurred largely by amalgamation of adjacent giant cells or further incorporation into established giant cells rather than continued fusion between single cells, implying that a limited number of cells in culture were capable of fusion in vitro and that these cell continued to be active in fusion at subsequent times. IL4 and GM CSF concentrations suitable for generating monocyte derived DC, boosted the fusion rates 2 to 3 fold and acted additively (Dugast, Gaudi and Toujas, 1997) , augmenting the formation of giant cells up to 5 fold over the basal rates in both normal and CVID cells. Inflammatory lymphokines, particularly IFN and TNF, dramatically induced the fusion rates in both normal and CVID monocytes, in keeping with previous findings that IFN is pivotal in giant cell formation (Most et al., 1990; Fais et al., 1994) . IFN also acted additively with other cytokines in promoting syncytia (Byrd, 1998) ; combinations of IFN with IL4 or GM CSF generating the highest fusion indices, over 5.5 or 6 fold the unstimulated monocyte fusion rates in CVID and normal cells, respectively, indicating that monokines and lymphokines can cooperate in monocyte fusion in normal and CVID cells alike. The reduction in giant cell formation in some CVID cell samples the presence of IL10, which acts to reduce cytokine synthesis by monocytes (de Waal et al., 1991) , would suggest that monocyte cytokine production can
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20 promote granuloma in CVID as supported by the potent fusogenic activity of CD14+ cell conditioned media. T cell mitogens were also potent inducers of normal as well as CVID fusion of monocytes and the equivalent activity of T cell and monocyte conditioned media in generating fusion of purified CD14 cell populations would indicate that both lymphokines and monokines are both sufficient to generate fusion. Similarly, supernatants from mitogen-stimulated PBMC were the major stimulus to fusion of normal monocytes (Postlethwaite et al., 1982) and were as effective inducers of cellular fusion as optimized cytokine concentrations when added to monocytes isolated from individuals with sarcoid (Most et al., 1997) . It is likely that monocytes and lymphocytes, and possibly other cells in vivo, produce cytokines that synergise in promoting granuloma formation. Th1 cells, producing INF (Wahlstrom et al., 2001) , probably aggregate in response to IL12 production by APCs (Rissoan et al., 1999) , leading to TNF production (Grunewald and Eklund, 2007) and further promotion of IL12 production in a pro-inflammatory loop in granulomatous foci. The importance of IFN in T cell recruitment and macrophage activation has been demonstrated in a mouse model where deficiency in IFN production prevents granuloma formation (Pearl et al., 2001) . CVID T cells synthesize more IFN and CVID monocytes higher amounts of IL12 than healthy individuals when stimulated with LPS (Cambronero et al., 2000) , contributing to a Th1 cytokine milieu that would mitigate against B cell class switching and antibody production.
Higher numbers of multinucleate cells and more nuclei per giant cell were generated in the CVID cell samples. However, the basal fusion index of untreated normal PBMC was augmented more by addition of IFNTNF and T cell mitogens than was the basal fusion rate of CVID cells. These observations would suggest that activated CVID peripheral monocytes (Scott-Taylor et al., 2006; Barbosa et al.,2012.) are less amenable to further cytokine induction in vitro. The comparatively low stimulus to CVID cell fusion
relative to normal cells of IL1 and PHA conditioned media may instead be inherent to an early T cell signal transduction defect in immunodeficiency (Zielen et al., 1994; Fiedler et al., 1987) . The greater reduction of the cytokine induced fusion rate for normal than CVID cells by incubation in anti-TNF antibody would indicate that monocyte fusion partially acts through TNF and that activation of monocytes in CVID is influential in giant cell formation. Elevated serum TNF levels in CVID are related to low CD4+ T cell counts (Aukrust et al., 1996) and to autoimmune phenomena (Knight and CunninghamRundles, 2006) . A high proportion of CVID individuals with granulomatous disease have a TNF receptor mutation that may predispose to inflammatory disease (Mullighan et al., 1997) . Anti-TNF treatment can reduce granulomatous lesions in CVID (Lin et al., 2006; Thatayatikom et al., 2005) and classical sarcoid disease (Wells et al., 2008) . In vitro anti- predominantly reduces inflammatory responses (Sewell et al.,1999; Ballow et al., 1989) and suppressed the production of IFN and IL12p70 from B cells (Bayry et al., 2011) .
Nevertheless, increased TNF and TNF receptor expression has been documented to IVIg therapy in IgG deficient (Farber et al., 1994) and CVID individuals (Sewell et al.,1999) and correlated with adverse inflammatory reactions (Aukrust et al., 1994) . IVIg infusion increased CD64 expression in monocytes (Ling et al., 1993) 
